Skip to main content

Table 4 Sick leave, additional treatments and adverse events. Use and length of paid sick leave, use of additional not per protocol treatments and reported adverse events for each treatment group. Values are numbers (percentages) if not otherwise stated. Chi-square test of independence and one-way analysis of variance for between groups association

From: Corticosteroid or placebo injection combined with deep transverse friction massage, Mills manipulation, stretching and eccentric exercise for acute lateral epicondylitis: a randomised, controlled trial

  Control Placebo injection with physiotherapy Corticosteroid injection with physiotherapy P
  (n = 60) (n = 58)   Chi‐square test
Paid sick leave during 52 week follow‐up     
Number (percentage) on leave 30 (52) 31 (56) 30 (55) 0.88
Duration of leave for those on sick‐leave:     
Days on full leave mean (95 % CI) 43.6 (22.0 to 65.1) 73.2 (34.2 to 112.2) 47.1 (30.0 to 64.3) 0.25*
Days on partial leave mean (95 % CI) 60.0 (23.1 to 96.9) 22.0 (6.8 to 37.3) 29.2 (11.2 to 47.2) 0.07*
Additional treatments     
Number of patients receiving additional treatments 13 (23) 12 (22) 16 (30) 0.63
Type of treatment:     
 Pain killers 6 (11) 4 (7) 2 (4) 0.37
 NSAIDs perorally 7 (13) 9 (16) 11 (20) 0.54
 topical NSAIDs 3 (5) 1 (2) 2 (4) 0.62
 other medication 3 (6) 0 (0) 3 (6) 0.22
 physiotherapy 4 (7) 1 (2) 9 (17) 0.02+
 other 6 (11) 4 (7) 4 (8) 0.76
Adverse Events     
Patients reporting adverse events 9 (16) 5 (9) 6 (11) 0.51
Type of adverse events     
 increased pain 2 (4) 2 (4) 0 (0) 0.37
 GI side effects** 8 (15) 3 (6) 6 (11) 0.30
 skin atrophy 0 (0) 0 (0) 0 (0)
  1. *: one‐way ANOVA
  2. **: heart burn/ dyspepsia, reflux symptoms, abdominal pain, gastritis, ulcer
  3. +: p < 0.05